Literature DB >> 20333315

A covalent HIV vaccine: is there hope for the future?

Sudhir Paul1, Stephanie A Planque, Yasuhiro Nishiyama, Carl V Hanson.   

Abstract

Entities:  

Year:  2009        PMID： 20333315      PMCID： PMC2842995          DOI： 10.2217/17460794.4.1.7

Source DB:  PubMed          Journal:  Future Virol        ISSN： 1746-0794            Impact factor:   1.831


× No keyword cloud information.
  12 in total

1.  Towards irreversible HIV inactivation: stable gp120 binding by nucleophilic antibodies.

Authors:  Yasuhiro Nishiyama; Sangeeta Karle; Yukie Mitsuda; Hiroaki Taguchi; Stephanie Planque; Maria Salas; Carl Hanson; Sudhir Paul
Journal:  J Mol Recognit       Date:  2006 Sep-Oct       Impact factor: 2.137

2.  Broad HIV-1 neutralization mediated by CD4-binding site antibodies.

Authors:  Yuxing Li; Stephen A Migueles; Brent Welcher; Krisha Svehla; Adhuna Phogat; Mark K Louder; Xueling Wu; George M Shaw; Mark Connors; Richard T Wyatt; John R Mascola
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

3.  Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.

Authors:  Stephanie Planque; Yukie Mitsuda; Hiroaki Taguchi; Maria Salas; Mary-Kate Morris; Yasuhiro Nishiyama; Robert Kyle; Pablo Okhuysen; Miguel Escobar; Robert Hunter; Haynes W Sheppard; Carl Hanson; Sudhir Paul
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

4.  Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.

Authors:  Bruce K Brown; Lindsay Wieczorek; Eric Sanders-Buell; Andrew Rosa Borges; Merlin L Robb; Deborah L Birx; Nelson L Michael; Francine E McCutchan; Victoria R Polonis
Journal:  Virology       Date:  2008-04-22       Impact factor: 3.616

5.  Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

Authors:  Sudhir Paul; Stephanie Planque; Yong-Xin Zhou; Hiroaki Taguchi; Gita Bhatia; Sangeeta Karle; Carl Hanson; Yasuhiro Nishiyama
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

6.  Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.

Authors:  Sudhir Paul; Sangeeta Karle; Stephanie Planque; Hiroaki Taguchi; Maria Salas; Yasuhiro Nishiyama; Beverly Handy; Robert Hunter; Allen Edmundson; Carl Hanson
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

7.  Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog.

Authors:  Yasuhiro Nishiyama; Yukie Mitsuda; Hiroaki Taguchi; Stephanie Planque; Maria Salas; Carl V Hanson; Sudhir Paul
Journal:  J Biol Chem       Date:  2007-08-29       Impact factor: 5.157

8.  Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease.

Authors:  B L Bermas; M Petri; J A Berzofsky; A Waisman; G M Shearer; E Mozes
Journal:  AIDS Res Hum Retroviruses       Date:  1994-09       Impact factor: 2.205

Review 9.  Catalytic antibodies to HIV: physiological role and potential clinical utility.

Authors:  Stephanie Planque; Yasuhiro Nishiyama; Hiroaki Taguchi; Maria Salas; Carl Hanson; Sudhir Paul
Journal:  Autoimmun Rev       Date:  2008-04-29       Impact factor: 9.754

10.  Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.

Authors:  James M Binley; Terri Wrin; Bette Korber; Michael B Zwick; Meng Wang; Colombe Chappey; Gabriela Stiegler; Renate Kunert; Susan Zolla-Pazner; Hermann Katinger; Christos J Petropoulos; Dennis R Burton
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103
View more
  1 in total

1.  Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice.

Authors:  Ehsan Ollah Jazaeri; Atiyeh Mahdavi; Asghar Abdoli
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.